Information Journal Paper
APA:
Copy. (2018). Generation of a novel long-acting thymosin alpha1-Fc fusion protein and its efficacy for the inhibition of breast cancer in vivo. BIOMEDICINE & PHARMACOTHERAPY, 108(-), 610-617. SID. https://sid.ir/paper/688449/en
Vancouver:
Copy. Generation of a novel long-acting thymosin alpha1-Fc fusion protein and its efficacy for the inhibition of breast cancer in vivo. BIOMEDICINE & PHARMACOTHERAPY[Internet]. 2018;108(-):610-617. Available from: https://sid.ir/paper/688449/en
IEEE:
Copy, “Generation of a novel long-acting thymosin alpha1-Fc fusion protein and its efficacy for the inhibition of breast cancer in vivo,” BIOMEDICINE & PHARMACOTHERAPY, vol. 108, no. -, pp. 610–617, 2018, [Online]. Available: https://sid.ir/paper/688449/en